Asian Development Bank, China-Based Lender Processing $2 Billion Loan For India


Asian Infrastructure Investment Bank and Asian Development Bank process loan for India

The China-based Asian Infrastructure Investment Bank (AIIB) and Asian Development (ADB) are currently processing a $ 2 billion loan for India to purchase COVID-19 vaccines.

Of the $ 2 billion loan, the Manila-based ADB is expected to fund $ 1.5 billion and the AIIB plans to provide $ 500 million, AIIB Vice President DJ Pandian said on Tuesday.

“The AfDB has agreed to finance $ 1.5 billion and the AIIB will supplement with an additional $ 500 million,” Pandian said.

The loan is under review by the AIIB board, he said, adding that India applied for it three months ago. About 667 million doses of COVID-19 vaccines are expected to be purchased with the loan, according to the Bank.

He said the vaccines will be procured by the Indian government through a competitive process and that the AfDB will administer the procurement system and implement it through the APVAX mechanism, or Asia-Pacific Vaccine Access Facility, of the AfDB.

India, which produces Covishield and Covaxin, recently took an inoculation milestone by administering 100 crore doses of the Covid-19 vaccine to its citizens against the deadly virus. India is also planning to resume vaccine exports and supply the vaccines to a number of countries.

In addition to funding various infrastructure projects in India, AIIB has also provided India $ 1.75 billion for COVID-19 relief budget support.

Mr. Pandian said the Beijing-based AIIB, of which India is the second largest shareholder after China, has so far approved 147 projects worth $ 28.9 billion.

Besides being the second largest shareholder, India became its biggest beneficiary by getting $ 6.7 billion for 28 projects, he told media here as the bank held its 2021 annual general meeting by video link.


For More News Go To DailyNewsCatch and Follow on Our Twitter Page DailyNewsCatch

Leave a Reply